01Facts
The case arose from a complaint regarding misbranded vaccines manufactured by Panacea Biotec Ltd.
In 2006, a consumer reported that while the outer carton was labeled as "Easy Five" (Pentavalent), the inner vial was labeled "Easy Four" (Tetravalent).
¶ 7-8The Drugs Inspector conducted an investigation to identify the supply chain and the specific offenders, concluding the identification process by April 2006.
¶ 29-30A formal complaint was filed in January 2009.
¶ 6The High Court of Kerala quashed the proceedings against the respondents primarily because they resided outside the Magistrate's territorial jurisdiction, and the Magistrate had failed to conduct a mandatory inquiry under Section 202 of the Cr.P.C.
¶ 13A connected matter involving Veekay Surgicals was also quashed on similar grounds and for insufficient compliance with Section 34 of the Drugs & Cosmetics Act.
¶ 5402Issues
i.1. Whether the primary complaint was barred by limitation under Sections 468 and 469 of the Cr.P.C.
¶ 26(a)ii.2. Whether the mandatory inquiry under Section 202(1) of the Cr.P.C. is required when the complainant is a public servant acting in official discharge of duty.
¶ 26(b)iii.3. Whether the High Court could quash proceedings against Directors under Section 34 of the Drugs & Cosmetics Act at the summoning stage.
¶ 5903Law Applied
The Court applied Section 469(1)(c) of the Cr.P.C., which stipulates that limitation commences on the first day the identity of the offender is known to the aggrieved person or investigating officer.
¶ 31It relied on Section 32 of the Drugs & Cosmetics Act, 1940, defining who can institute prosecution.
¶ 35Crucially, the Court harmonized Section 200 with Section 202(1) of the Cr.P.C., applying the principle from *Cheminova India Limited v. State of Punjab* (2021), which holds that public servants are placed on a different pedestal; thus, the exemptive proviso of Section 200 also influences the necessity of inquiry under Section 202.
¶ 16, 40Section 34 of the Drugs & Cosmetics Act regarding vicarious liability of persons in charge of a company was also considered.
¶ 18, 59Provisions in the judgment · 14 · Linked ones open on LawLens
Drugs and Cosmetics Act, 1940 Section 18Section 17Section 27Section 34Section 32Section 21Section 23
Code of Criminal Procedure, 1973 Section 482Section 473Section 202Section 200Section 293Section 468Section 469
04Reasoning
Regarding limitation, the Court reasoned that under Section 469(1)(c), the 3-year clock only began ticking on April 18, 2006, when the identity of all accused persons was finalized through investigation, making the January 2009 filing timely.
¶ 36Regarding Section 202, the Court held that the High Court erred in treating the inquiry as a mandatory hurdle for public servants.
¶ 40-40.1Since Section 200 Cr.P.C. expressly waives the examination of a public servant, and because the complaint was backed by official investigation/reports, they stand on a different footing than private complainants.
¶ 40-40.1The Court found the *Birla Corporation* precedent inapplicable as it involved a private complainant.
¶ 40.2Regarding the liability of Directors under Section 34, the Court observed that "in-charge" status is a question of fact to be determined during trial, making the High Court's quashing premature.
¶ 5905Holding
The Supreme Court allowed the appeals by the State and set aside the High Court judgments.
¶ 44, 59It held that: (i) the complaint was within the limitation period as per Section 469(1)(c).
(ii) the mandatory inquiry under Section 202(1) is not an absolute requirement when a complaint is filed by a public servant in their official capacity.
¶ 40.1and (iii) the determination of vicarious liability of Directors must be left to the Trial Court.
¶ 59The Court directed the concerned Magistrate to issue fresh summons and proceed with the trial.
¶ 60Original Court PDF
The State of Kerala & Anr. v. M/s. Panacea Biotec Ltd. & Anr. 2026 INSC 200
Click to open original judgment
Original judgment, available to read, download and summarize on LawLens.in
